TNFα and IL-8 vitreous concentrations variations with two antidiabetic therapies in patients with proliferative diabetic retinopathy: an observational study

dc.contributor.authorÓscar Morales-López
dc.contributor.authorOctavio Rodríguez‐Cortés
dc.contributor.authorPedro López‐Sánchez
dc.contributor.authorHéctor Javier Pérez-Cano
dc.contributor.authorOmar García-Liévanos
dc.contributor.authorVirgilio Lima-Gómez
dc.contributor.authorSelma Alin Somilleda-Ventura
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:27:11Z
dc.date.available2026-03-22T14:27:11Z
dc.date.issued2024
dc.descriptionCitaciones: 2
dc.identifier.doi10.1186/s12886-024-03659-4
dc.identifier.urihttps://doi.org/10.1186/s12886-024-03659-4
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/46595
dc.language.isoen
dc.publisherBioMed Central
dc.relation.ispartofBMC Ophthalmology
dc.sourceInstituto Politécnico Nacional
dc.subjectMedicine
dc.subjectDiabetic retinopathy
dc.subjectObservational study
dc.subjectDiabetes mellitus
dc.subjectOphthalmology
dc.subjectInternal medicine
dc.subjectTumor necrosis factor alpha
dc.titleTNFα and IL-8 vitreous concentrations variations with two antidiabetic therapies in patients with proliferative diabetic retinopathy: an observational study
dc.typearticle

Files